A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
6/26/2026
BreakingCornealLaserOptometryScope of Practice
Vermont Expands ODs’ Scope to Include SLT, LPI, YAG Capsulotomy, Crosslinking
Vermont has become the 17th US state to pass a law expanding optometrists’ scope of practice to include in-office laser procedures. Senate Bill 64, signed into law by Gov. Phil Scott on June 18, gr...
6/26/2026
BreakingGlaucomaPharma
Théa Pharma Launches Zolymbus Bimatoprost Gel for Glaucoma in the US
Théa Pharma, the Massachusetts-based subsidiary of France-based Théa, announced June 15 that it had launched Zolymbus (bimatoprost ophthalmic gel) 0.01% in the US. Thepreservative-free formulation ...
6/26/2026
BreakingDeviceGlaucomaSurgical
Hexiris Showcases Glaucoma Devices Targeting Office-Based Surgery
Canada’s Hexiris Ophthalmics reports that it is showcasing at ophthalmic meetings its glaucoma device candidates targeting office-based surgery, with an eye toward a commercial launch in 2026. Surg...
6/18/2026
CornealMeetingNewsletter
EBAA Annual Meeting Underlines Human Impact of Donation
The 2026 Eye Bank Association of America (EBAA) annual meeting brought together approximately 250 eye bank technicians, medical directors, corneal surgeons, and industry professionals June 3-6 in I...
6/26/2026
BreakingCataractDealsPharma
Formosa Licenses Clobetasol Drops to Samil for Vietnam
Taiwan-based Formosa Pharmaceuticals announced June 11 that it had expanded its licensing agreement with Samil Pharmaceuticals for clobetasol propionate 0.05% eye drops for postsurgical inflammatio...
6/26/2026
BreakingDry EyeRetina
Scope Health Adds Vision Support and Eye Comfort Eyetamins to its Optase Product Line
Scope Health, of New York, announced June 17 that it had added Eyetamins Vision Support and Eye Comfort versions to its Optase line of eyelid hygiene and ocular lubricant products. The Eye Comfort ...
6/26/2026
BreakingDry EyePharma
Ocusoft Introduces Retaine Ultra PF Preservative-Free Artificial Tears
Ocusoft, of Rosenberg, Texas, announced on June 17 the launch of Retaine Ultra PF, a lubricating eye drop available in a preservative-free multi-dose bottle. Its active ingredients include polyethy...
6/26/2026
BreakingGlaucomaIndustryPharma
Essential Pharma Appoints Becki Morison as Chief Executive Officer
UK-based Essential Pharma announced June 18 that it had appointed Becki Morison as chief executive officer, effective July 1. Morison succeeds Simon Ball, who has served as interim CEO since Novemb...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.